Consensus Gentex Corporation

Equities

GNTX

US3719011096

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
34.25 ^USD	+1.00%		+0.91%	+4.87%

Mar. 20	B. Riley Securities Raises Gentex's PT to $44 From $42 After Investor Day, Notes 'Robust' Growth; Maintains Buy Rating	MT
Feb. 21	Gentex Insider Sold Shares Worth $437,450, According to a Recent SEC Filing	MT

Evolution of the average Target Price on Gentex Corporation

Price target over the last 5 years

History of analyst recommendation changes

37c3a5630be8a00ceef9e9f40.2EJsm0yTxwCOq00IzsX3hIADt5ncOk7nesAeNhB1bO8.kjEBwgajnjfd5HpFhpe119IuhtKTVBnQDqlYUkYqHYS-LTTsdP_3M8vjIg~2b12fe7a98466cce6d2fb4668990a53e

Analyst Recommendations on Gentex Corporation

B. Riley Securities Raises Gentex's PT to $44 From $42 After Investor Day, Notes 'Robust' Growth; Maintains Buy Rating	Mar. 20	MT
Goldman Sachs Adjusts Price Target on Gentex to $35 From $31, Maintains Neutral Rating	Jan. 29	MT
B. Riley Raises Gentex's PT to $42 From $36 After Above-Consensus Q4 2023 Results, Maintains Buy Rating	Jan. 29	MT
JPMorgan Adjusts Gentex Price Target to $37 From $36, Maintains Neutral Rating	Jan. 25	MT
Goldman Sachs Trims Price Target on Gentex to $31 From $33, Maintains Neutral Rating	23-10-30	MT
B. Riley Lowers Gentex's Price Target to $36 From $40, Notes Elevated Economic Uncertainty, Multiple Compression; Maintains Buy Rating	23-10-30	MT
Goldman Sachs Adjusts Price Target on Gentex to $33 From $29, Maintains Neutral Rating	23-07-31	MT
B, Riley Raises Gentex's PT to $40 From $35 After Higher-Than-Expected Q2 Results, Keeps Buy Rating	23-07-31	MT
JPMorgan Adjusts Price Target on Gentex to $30 From $28, Maintains Neutral Rating	23-07-20	MT
BofA Securities Upgrades Gentex to Neutral From Underperform	23-07-06	MT
JPMorgan Adjusts Gentex's Price Target to $28 From $27, Keeps Neutral Rating	23-05-01	MT
Goldman Sachs Adjusts Price Target on Gentex to $29 From $28, Maintains Neutral Rating	23-05-01	MT
Goldman Sachs Adjusts Price Target on Gentex to $28 From $26, Maintains Neutral Rating	23-01-30	MT
Goldman Sachs Upgrades Gentex to Neutral From Sell, Adjusts Price Target to $26 From $24	22-12-14	MT
Jefferies Lowers Gentex's Price Target to $33 From $36, Maintains Buy Rating	22-07-25	MT
B. Riley Lowers Gentex's Price Target to $35 from $37.50, Says Production Headwinds Weigh on Q2 Results; Keeps Buy Rating	22-07-25	MT
BNP Paribas Exane Initiates Coverage on Gentex With Outperform Rating	22-04-11	MT
BofA Securities Adjusts Price Target on Gentex to $31 From $26, Keeps Underperform Rating	22-04-06	MT
JPMorgan Adjusts Gentex Price Target to $31 From $33, Maintains Neutral Rating	22-03-24	MT
Goldman Sachs Lowers Gentex's Price Target to $25 From $28, Maintains Sell Rating	22-03-22	MT
B. Riley Lowers Gentex's Price Target to $37.50 from $41, Says Supply Chain Headwinds Likely to Persist Through H1; Keeps Buy Rating	22-01-31	MT
GENTEX : JPMorgan Adjusts Gentex's Price Target to $37 from $34, Keeps Neutral Rating	21-10-21	MT
GENTEX : Goldman Sachs Adjusts Gentex's PT to $30 from $32, Keeps Sell Rating	21-09-27	MT
GENTEX : JPMorgan Adjusts Gentex's Price Target to $34 from $37, Keeps Neutral Rating	21-07-26	MT
GENTEX : KeyBanc Adjusts Gentex's Price Target to $40 from $43, Keeps Overweight Rating	21-07-26	MT